Phae 2A Study of a Vaginal Ring Containing Dapivirine in Adolescent Females

Trial Profile

Phae 2A Study of a Vaginal Ring Containing Dapivirine in Adolescent Females

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2017

At a glance

  • Drugs Dapivirine (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Sponsors International Partnership for Microbicides
  • Most Recent Events

    • 18 Nov 2016 Status changed from recruiting to completed.
    • 09 Sep 2015 Protocol has been amended in the primary endpoint, time frame changed from 3 months to 6 months.
    • 09 Sep 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top